Centers

test

Chulalongkorn University Drug Discovery and Drug Development Research Center (Chula4DR)

VMCC, University of Michigan

sfgd

Read more
Chulalongkorn Drug Discovery and Drug Development Research Center (Chula4DR) was established in 2017, with the aim to facilitate advancement of academic drug discovery and drug development research by leveraging innovations and sciences...
Read more

The VMCC is an on-campus core facility for the design and synthesis of drug-like molecules and diagnostic probes used in biomedical investigations.

Our Mission: To assist biomedical researchers in translating novel therapeutic hypotheses into...
Read more

Partnerships

Events

Jobs

Sanofi and Weill Cornell Medical College to Discover New Drus to Treat Tuberculosis

Sanofi has entered into a new collaboration with Dr.Carl Nathan's laboratory at Weill Cornell Medical College to screen existing compounds and develop new compounds to shorten the course of treatment of tuberculosis and increase effectiveness of...

 
View all

Cerecor Partners with Johns Hopkins Brain Science Institute to Treat Schizophrenia

Cerecor a Baltimore based company has taken an option with Johns Hopkins University to license D-Amino Acid Oxidase inhibitors (DAAO) to treat Schizophrenia. The DAAO inhibitor molecules are currently being developed by researchers at the Johns...

 
View all

TB Drug Accelerator

  • The TB Drug Accelerator Programme aims to speed up the discovery and development of novel compounds against tuberculosis (TB).

 
View all

No EVENTS for listing

No Job Posts

Sponsors

Pfizer Roche HL Tocris Sigma-Aldrich Xenotech Xenotech Eurofins Pfizer Roche HL Tocris Sigma-Aldrich Xenotech Xenotech Eurofins
View All